Drugs & Targets FDA approves Keytruda for adjuvant treatment of melanoma February 22, 2019Vol.45 No.08
Drugs & Targets FDA accepts IND for TR1801-ADC, an ADC targeting cMet positive solid tumors February 22, 2019Vol.45 No.08
Drugs & Targets FDA grants priority review to Merck’s sBLA for Keytruda monotherapy in SCLC February 22, 2019Vol.45 No.08
Drugs & Targets FDA publishes revised draft guidance for investigational tobacco products February 22, 2019Vol.45 No.08
Drugs & Targets European Commission approves Sprycel + chemo for pediatric February 15, 2019Vol.45 No.07
Drugs & Targets FDA grants Priority Review for Keytruda in head and neck squamous cell carcinoma February 15, 2019Vol.45 No.07
Drugs & Targets FDA accepts sBLA and grants Priority Review for Bavencio + Inlyta in RCC February 15, 2019Vol.45 No.07
Drugs & TargetsFree FDA approves therapy for adult patients with blood clotting disorder February 08, 2019Vol.45 No.06
Drugs & TargetsFree Pfizer given positive CHMP opinion for Vizimpro in NSCLC February 08, 2019Vol.45 No.06
Drugs & TargetsFree Genentech submits sBLA for Kadcyla for breast cancer February 08, 2019Vol.45 No.06
